135 related articles for article (PubMed ID: 36181032)
1. Prognostic and clinicopathological significance of nm23-H1 expression in non-small cell lung cancer: A meta-analysis.
Li D; Li W; Tian C; Pang Y; Xu L; Wang Y; Xu X
Medicine (Baltimore); 2022 Sep; 101(39):e30815. PubMed ID: 36181032
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
Min SH; Zheng QQ
Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763
[TBL] [Abstract][Full Text] [Related]
3. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
[TBL] [Abstract][Full Text] [Related]
4. Low expression of nm23-H1 associates with poor survival of nasopharyngeal carcinoma patients: A prisma-compliant meta-analysis.
Yuan C; Xu XH; Xu L; Sun M; Ni LH; Liu Y; Ran F; Wang XL; Chen Z; Zhang K; Zeng G
Medicine (Baltimore); 2017 Jun; 96(24):e7153. PubMed ID: 28614246
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non-small cell lung cancer.
Hsu NY; Chen CY; Hsu CP; Lin TY; Chou MC; Chiou SH; Chow KC
Oncol Rep; 2007 Jul; 18(1):81-5. PubMed ID: 17549350
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
[TBL] [Abstract][Full Text] [Related]
7. Correlation between NM23 protein overexpression and prognostic value and clinicopathologic features of ovarian cancer: a meta-analysis.
Fang J; Guo X; Zheng B; Han W; Chen X; Zhu J; Xie B; Liu J; Luan X; Yan Y; He Z; Li H; Qiao C; Yu J
Arch Gynecol Obstet; 2018 Feb; 297(2):449-458. PubMed ID: 29274004
[TBL] [Abstract][Full Text] [Related]
8. [Expression and clinical significance of nm23-H1 and MUC-1 in peripheral T-cell lymphoma].
Huang HQ; Pan ZH; Lin XB; Wang BF; Hou JH; Zhang Y; Wu QL
Ai Zheng; 2006 Dec; 25(12):1517-23. PubMed ID: 17166378
[TBL] [Abstract][Full Text] [Related]
9. A prognostic role for Nm23-H1 in laryngeal carcinoma treated with postoperative radiotherapy: an introductory investigation.
Lionello M; Blandamura S; Agostini M; Staffieri C; Lovato A; Tealdo G; Favaretto N; Giacomelli L; Loreggian L; Staffieri A; Marioni G
Eur Arch Otorhinolaryngol; 2013 Jan; 270(1):197-203. PubMed ID: 23010793
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
11. Prognostic and clinicopathological value of NM23 expression in patients with breast cancer: A systematic review and meta-analysis.
Han W; Zhang C; Cao FY; Cao F; Jiang L; Ding HZ
Curr Probl Cancer; 2017; 41(1):80-93. PubMed ID: 28161101
[TBL] [Abstract][Full Text] [Related]
12. Association between nm23-H1 expression, proliferation and apoptosis in non-small cell lung carcinomas.
Volm M; Mattern J; Koomägi R
Clin Exp Metastasis; 1998 Oct; 16(7):595-602. PubMed ID: 9932606
[TBL] [Abstract][Full Text] [Related]
13. Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5.
Ai C; Ma G; Deng Y; Zheng Q; Gen Y; Li W; Li Y; Zu L; Zhou Q
Thorac Cancer; 2020 Mar; 11(3):640-650. PubMed ID: 32022430
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of nm23-H1 in stage I non-small cell lung cancer: a useful marker in prediction of metastases.
Lai WW; Wu MH; Yan JJ; Chen FF
Ann Thorac Surg; 1996 Nov; 62(5):1500-4. PubMed ID: 8893591
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of nm23-H1 expression in esophageal squamous cell carcinoma.
Wang LS; Chow KC; Lien YC; Kuo KT; Li WY
Eur J Cardiothorac Surg; 2004 Aug; 26(2):419-24. PubMed ID: 15296908
[TBL] [Abstract][Full Text] [Related]
16. Nm23-H1-stabilized hnRNPA2/B1 promotes internal ribosomal entry site (IRES)-mediated translation of Sp1 in the lung cancer progression.
Hung CY; Wang YC; Chuang JY; Young MJ; Liaw H; Chang WC; Hung JJ
Sci Rep; 2017 Aug; 7(1):9166. PubMed ID: 28831131
[TBL] [Abstract][Full Text] [Related]
17. Nm23-H1 inhibits hypoxia induced epithelial-mesenchymal transition and stemness in non-small cell lung cancer cells.
Wu CE; Zhuang YW; Zhou JY; Liu SL; Zou X; Wu J; Wang RP; Shu P
Biol Chem; 2019 May; 400(6):765-776. PubMed ID: 30763256
[TBL] [Abstract][Full Text] [Related]
18. Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer.
Ozturk E; Aksoy SA; Ugras N; Tunca B; Ceylan S; Tezcan G; Yilmazlar T; Yerci O; Egeli U; Cecener G
APMIS; 2018 Feb; 126(2):99-108. PubMed ID: 29700912
[TBL] [Abstract][Full Text] [Related]
19. [Expression and clinical significance of vascular endothelial growth factor-C and nm23-H1 in stage II and III colorectal carcinomas].
Geng QQ; Li Y; Tang CH; Li EX; Wu YY; Zhang GJ
Zhonghua Zhong Liu Za Zhi; 2013 Jun; 35(6):439-44. PubMed ID: 24119904
[TBL] [Abstract][Full Text] [Related]
20. nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma.
Zafon C; Obiols G; Castellví J; Tallada N; Galofré P; Gemar E; Mesa J; Simó R
J Clin Endocrinol Metab; 2001 Aug; 86(8):3975-80. PubMed ID: 11502841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
